Dialysis Market

Overview

The global Dialysis Market was valued at USD 118.5 billion in 2025 and is projected to reach USD 195.5 billion by 2034, growing at a CAGR of 5.7% during the forecast period (2026–2034). The market is driven by the rising global prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), growing rates of diabetes and hypertension, an aging population, and continued expansion of home-based dialysis therapy options.

The Dialysis Market refers to the healthcare industry involved in technologies, devices, and services used to treat patients with kidney failure by removing waste and excess fluids from the blood. The market is shifting from facility-based in-center hemodialysis toward home-based and portable dialysis solutions, driven by compact device innovations, patient preference for greater flexibility, and cost-efficient care models. Industry restructuring, including the standalone launch of kidney-care businesses from major players such as Baxter and Medtronic, is further reshaping competition through integrated technology, services, and value-based care approaches.

Government initiatives, including updates to the U.S. Centers for Medicare & Medicaid Services’ End-Stage Renal Disease Prospective Payment System, are influencing dialysis provider economics by increasing bundled payment support and encouraging continued investment in dialysis infrastructure, home therapy expansion, and patient-centered care models.

By region, North America held the largest share of the market in 2025, supported by a high prevalence of diabetes and hypertension, favorable Medicare reimbursement policies, and a strong presence of leading dialysis providers and device manufacturers. Asia-Pacific is expected to be the fastest-growing region during the forecast period, driven by a rapidly expanding CKD and ESRD patient population, and growing dialysis infrastructure investment across China, India, and Japan.

Market Size & Share

Market Dynamics

KEY MARKET TREND

Shift Toward Home-Based and Portable Dialysis Systems Emerging as a Transformational Trend

• Dialysis providers and device manufacturers are increasingly prioritizing compact, easy-to-use hemodialysis and peritoneal dialysis systems designed for use in the home rather than in traditional dialysis centers, reducing facility-based infrastructure requirements.
• Newly cleared home hemodialysis systems are lowering the technical barrier to home therapy adoption, expanding the eligible patient population beyond those historically limited to peritoneal dialysis at home.
• Growing corporate restructuring among device and service providers — including the separation of kidney-care divisions into standalone companies — is accelerating focused investment in home and portable dialysis technology.
• Quanta Dialysis Technologies received U.S. FDA 510(k) clearance for home use of its Quanta Dialysis System, expanding its addressable use from hospital and in-center settings to the home hemodialysis market.

KEY MARKET DRIVER

Rising Global Prevalence of Chronic Kidney Disease and End-Stage Renal Disease is Driving Market Growth

• The growing global burden of diabetes and hypertension, the two leading causes of chronic kidney disease, continues to expand the population requiring long-term renal replacement therapy.
• An aging global population is increasing the incidence of age-related kidney function decline, adding to the pool of patients requiring dialysis for both acute and chronic kidney conditions.
• The increasing adoption of home-based dialysis therapies, supported by advances in compact dialysis devices, remote monitoring technologies, and patient preference for greater flexibility, is accelerating market growth by expanding access to dialysis beyond traditional in-center facilities.
• The U.S. CMS updated its End-Stage Renal Disease Prospective Payment System rule, increasing the Medicare bundled base payment rate for dialysis facilities from USD 273.82 to USD 281.71 per treatment. This adjustment is expected to increase total payments to ESRD facilities by approximately 2.2%, supporting provider sustainability and continued investment in dialysis services.

KEY MARKET OPPORTUNITY

Expansion of Value-Based and Integrated Kidney Care Models Creates Significant Market Opportunity

• Growing adoption of value-based kidney care arrangements is creating opportunities for companies that combine dialysis technology, home therapy support, and care coordination into integrated offerings.
• Rising investment in newly independent kidney-care companies spun out from larger diversified medical technology firms is expanding dedicated research and commercial focus on dialysis-specific innovation.
• Growing demand for portable and wearable dialysis technologies is opening new addressable use cases in acute care, critical care, and remote or underserved geographies with limited dialysis center access.
• Carlyle completed the acquisition of Baxter’s Kidney Care business, resulting in the formation of Vantive as an independent kidney-care company focused on providing vital-organ therapy solutions across hospital, clinic, and home dialysis settings. The acquisition strengthens the dialysis market landscape by enabling greater focus on innovation, technology integration, and patient-centered renal care solutions.

Dialysis Market Size, 2025-2034 (USD Billion)

Segmentation Analysis

Analysis by Type

Hemodialysis held the largest market share in 2025, supported by its established role as the standard-of-care renal replacement therapy for the majority of patients with end-stage renal disease, widespread availability across dialysis centers and hospitals worldwide, extensive clinical adoption, and continuous advancements in dialysis equipment, treatment efficiency, and patient monitoring technologies. The segment accounted for approximately 79% of the market, driven by its proven effectiveness, strong healthcare infrastructure support, and broad acceptance among providers and patient.

Peritoneal Dialysis is projected to grow at the fastest CAGR during the forecast period, driven by increasing patient and payer preference for home-based treatment options, lower infrastructure requirements compared with in-center hemodialysis, and rising adoption of flexible dialysis modalities. Growing clinical evidence demonstrating comparable treatment outcomes, improved quality of life, and advancements in home dialysis technologies are further accelerating segment growth.

Type categories include

• Hemodialysis (Dominating Segment)
• Peritoneal Dialysis (Highest CAGR Segment)

Analysis by Offering

Services held the largest market position in 2025, supported by the recurring and essential nature of dialysis treatment delivery, which requires continuous clinical support, trained healthcare professionals, facility operations, and patient management across dialysis centers, hospitals, and home-care programs. The segment’s dominance is driven by the ongoing demand for maintenance dialysis sessions, monitoring services, and integrated care solutions for patients with end-stage renal disease.

Equipment is projected to grow at the fastest CAGR during the forecast period, supported by increasing adoption of compact and portable hemodialysis and peritoneal dialysis systems for home-based care, along with rising replacement of aging in-center dialysis machines with advanced, connected, and digitally enabled devices. Technological advancements in automation, remote monitoring, and treatment efficiency are further driving demand for next-generation dialysis equipment.

Offering categories include

• Services (Dominating Segment)
• Equipment (Highest CAGR Segment)
• Consumables
• Drugs

Analysis by End User

Dialysis Centers & Hospitals held the leading market position in 2025, supported by favorable reimbursement frameworks for facility-based renal care, the need for close clinical monitoring of newly diagnosed end-stage renal disease patients, and the continued expansion of independent dialysis center networks. The segment’s growth is further driven by the availability of specialized nephrology teams, established treatment infrastructure, higher patient volumes, and the continued preference for in-center dialysis among patients requiring regular and supervised renal replacement therapy.

Home Care is projected to grow at the fastest CAGR during the forecast period, supported by increasing patient preference for home-based hemodialysis and peritoneal dialysis, favorable payer incentives promoting lower-cost home therapies, and the expanding availability of simplified, home-cleared dialysis systems. Growth is further driven by advancements in remote patient monitoring, improved caregiver support, greater treatment flexibility, and ongoing initiatives to expand access to home-based kidney care.

End User categories include

• Dialysis Centers & Hospitals (Dominating Segment)
• Home Care (Highest CAGR Segment)

Analysis by Indication

End-Stage Renal Disease held the largest market position in 2025, supported by the lifelong need for renal replacement therapy among patients who are not eligible for or awaiting kidney transplantation. The segment continues to drive sustained demand for both hemodialysis and peritoneal dialysis products and services due to the chronic nature of ESRD, increasing disease prevalence, improved patient survival, and the requirement for regular, long-term dialysis treatment and clinical monitoring.

Acute Kidney Injury is projected to grow at the fastest CAGR during the forecast period, driven by the rising incidence of AKI in hospital and intensive care settings, increasing use of continuous renal replacement therapy (CRRT) and acute dialysis for short-term renal support, and growing awareness of early intervention in critically ill patients. Advancements in critical care technologies, expanding ICU capacity, and improving access to specialized renal care are further contributing to the segment's growth.

Indication categories include

• End-Stage Renal Disease (Dominating Segment)
• Acute Kidney Injury (Highest CAGR Segment)

By Region

Dialysis Market Share 2025, (CAGR)

North America

41%

South America

xx%

Europe

27%

Middle East Africa

xx%

Asia Pacific

xx%

North America held the largest market share in 2025, supported by the high prevalence of diabetes and hypertension, favorable Medicare reimbursement under the End-Stage Renal Disease Prospective Payment System, and the presence of leading dialysis providers and device manufacturers. The region accounted for approximately 41% of the global market. The United States dominates the regional market due to its large end-stage renal disease (ESRD) patient population, extensive dialysis center network, widespread adoption of advanced dialysis technologies, and supportive reimbursement policies. Canada contributes significantly through its publicly funded healthcare system, expanding home dialysis programs, and continued investments in improving access to renal care across urban and remote communities.

Asia-Pacific is projected to grow at the fastest CAGR during the forecast period, driven by a rapidly expanding chronic kidney disease (CKD) and end-stage renal disease (ESRD) patient population, rising diabetes and hypertension prevalence, increasing healthcare expenditure, and expanding dialysis center and home-therapy infrastructure across the region. China is leading regional growth through continuous expansion of dialysis services, improving healthcare access, and a large CKD patient base. India is witnessing strong market expansion due to the rising burden of kidney disease, increasing government support for dialysis programs, and growing investments in dialysis center networks. Japan remains a mature market with one of the world's largest dialysis populations, supported by advanced treatment technologies and high adoption of home and in-center dialysis solutions. South Korea is experiencing steady growth through investments in advanced renal care technologies, expanding healthcare infrastructure, and increasing adoption of home-based dialysis and digital patient monitoring systems.

Countries and Regions Covered

North America (Dominating Region)

• United States (Largest Country Market)
• Canada
• Mexico

Asia-Pacific (Fastest Growing Region)

• China (Largest Country Market)
• India (Fastest-Growing Country Market)
• Japan
• South Korea
• Rest of Asia-Pacific

Europe

• Germany (Largest Country Market)
• United Kingdom
• France
• Rest of Europe

Latin America

• Brazil (Largest Country Market)
• Argentina
• Rest of Latin America

Middle East & Africa

• Saudi Arabia (Largest Country Market)
• United Arab Emirates (Fastest-Growing Country Market)
• Rest of Middle East & Africa

Market Share

The Dialysis Market is consolidated, with a small number of large, vertically integrated device manufacturers and dialysis providers, ncluding Fresenius Medical Care, DaVita, and Vantive holding substantial global share through combined device manufacturing, dialysis center networks, and pharmaceutical portfolios. This concentration is layered with a broader base of specialized device manufacturers, including several long-established Japanese and European dialyzer and machine producers, alongside newer entrants offering compact and home-focused dialysis systems. Key success factors include reimbursement-aligned cost efficiency, dialysis center network scale, clinical outcomes track record, and the ability to support both in-center and home therapy modalities. Leading companies are prioritizing home-therapy technology investment, value-based kidney-care partnerships, and continued corporate restructuring, including recent standalone spin-offs to sharpen strategic focus and capture growth in home and portable dialysis.

Key Players

• Fresenius Medical Care (Germany)
• DaVita Inc. (US)
• Vantive (US)
• U.S. Renal Care, Inc. (US)
• Diaverum Deutschland GmbH (Germany)
• Nipro Corporation (Japan)
• B. Braun Melsungen AG (Germany)
• Asahi Kasei Corporation (Japan)
• Becton, Dickinson and Company (US)
• Nikkiso Co., Ltd. (Japan)
• Toray Medical Co., Ltd. (Japan)
• Outset Medical, Inc. (US)
• Terumo Corporation (Japan)
• JMS Co., Ltd. (Japan)
• Teleflex (US)

Recent Market Developments

• In September 2025, Outset Medical and Northwest Kidney Centers announced a partnership whereby Northwest Kidney Centers will integrate Outset’s Tablo Hemodialysis System into its service offerings for home dialysis.
• In November 2025, Vantive launched HomeAdvantage, a digitally enabled home therapy ecosystem that simplifies home dialysis through integrated digital tools and patient support, strengthening the shift toward connected, patient-centric home dialysis solutions in the dialysis market.
• In December 2025, Nikkiso launched the DBB-06 PRO hemodialysis machine for the U.S. market, enhancing dialysis treatment efficiency and supporting growing demand for advanced, user-friendly hemodialysis technologies.

Frequently Asked Questions

Key Questions Answered

Request a Sample

1

What is Dialysis?

2

What is the CAGR of the Dialysis Market?

3

Which type leads the Dialysis Market?

4

Which end user dominates the Dialysis Market?

5

Which indication has the highest market share?

6

What are the latest trends in the Dialysis Market?

7

Who are the end users of Dialysis?

Why Choose IG Transformation

Speak to Analyst

Strong Industry Focus

Extensive Product Offerings

Customer Research Services

Robust Research Methodology

Comprehensive Reports

Latest Technological Developments

Value Chain Analysis

Potential Market Opportunities

Growth Dynamics

Quality Assurance

Post-sales Support

Regular Report Updates